Negative bone scintigraphy in wild-type transthyretin cardiac amyloidosis
Abstract Background Amyloidosis is a rare systemic disease due to the extracellular tissue deposition of a fibrillar-shaped misfolded protein, called amyloid. Only two types of proteins commonly affect the heart leading to an infiltrative cardiomyopathy: immunoglobulin light chain and transthyretin...
Main Authors: | Nicolò Martini, Stefania Rizzo, Cristiano Sarais, Alberto Cipriani |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-10-01
|
Series: | BMC Cardiovascular Disorders |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12872-020-01749-x |
Similar Items
-
Prevalence of Incidental Findings Suspicious for Transthyretin Cardiac Amyloidosis among Patients Undergoing Bone Scintigraphy: A Systematic Review and a Meta-Analysis
by: Giorgio Treglia, et al.
Published: (2023-09-01) -
Cardiac scintigraphy-centered diagnostic process in transthyretin cardiac amyloidosis
by: Ilknur Ak Sivrikoz, et al.
Published: (2020-07-01) -
The short and long‐term characteristics and outcomes of patients with grade 1 myocardial uptake on cardiac scintigraphy
by: Osnat Itzhaki Ben Zadok, et al.
Published: (2023-06-01) -
Diagnostic Accuracy of Bone Scintigraphy for the Histopathological Diagnosis of Cardiac Transthyretin Amyloidosis—A Retrospective Austrian Multicenter Study
by: Nicolas Verheyen, et al.
Published: (2022-11-01) -
Specific Therapy for Transthyretin Cardiac Amyloidosis: A Systematic Literature Review and Evidence‐Based Recommendations
by: Nuno Marques, et al.
Published: (2020-10-01)